Strs Ohio Raises Stake in Concentrix Co. (NASDAQ:CNXC)

Strs Ohio lifted its stake in shares of Concentrix Co. (NASDAQ:CNXCGet Rating) by 6.1% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 6,961 shares of the company’s stock after acquiring an additional 402 shares during the period. Strs Ohio’s holdings in Concentrix were worth $777,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also recently modified their holdings of the company. FMR LLC grew its position in Concentrix by 24.4% in the second quarter. FMR LLC now owns 7,870,341 shares of the company’s stock worth $1,067,534,000 after acquiring an additional 1,545,526 shares during the period. Price T Rowe Associates Inc. MD increased its position in shares of Concentrix by 1,657.6% during the 2nd quarter. Price T Rowe Associates Inc. MD now owns 376,551 shares of the company’s stock worth $51,075,000 after purchasing an additional 355,127 shares during the last quarter. Allspring Global Investments Holdings LLC raised its holdings in Concentrix by 1,124.2% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 150,635 shares of the company’s stock valued at $16,814,000 after buying an additional 138,330 shares during the period. Prudential Financial Inc. lifted its position in Concentrix by 131.2% in the first quarter. Prudential Financial Inc. now owns 205,214 shares of the company’s stock valued at $34,181,000 after buying an additional 116,465 shares during the last quarter. Finally, Invesco Ltd. boosted its stake in Concentrix by 47.4% during the first quarter. Invesco Ltd. now owns 308,472 shares of the company’s stock worth $51,380,000 after buying an additional 99,159 shares during the period. Institutional investors and hedge funds own 92.31% of the company’s stock.

Concentrix Price Performance

CNXC stock opened at $145.14 on Tuesday. The business’s fifty day moving average price is $125.86 and its 200 day moving average price is $125.82. Concentrix Co. has a 12-month low of $108.57 and a 12-month high of $208.48. The company has a current ratio of 1.67, a quick ratio of 1.67 and a debt-to-equity ratio of 0.91. The company has a market capitalization of $7.50 billion, a PE ratio of 16.84, a P/E/G ratio of 1.00 and a beta of 0.54.

Analysts Set New Price Targets

Separately, Barrington Research lowered their price objective on shares of Concentrix from $183.00 to $174.00 and set an “outperform” rating for the company in a research report on Friday, September 30th.

Insiders Place Their Bets

In other news, Director Dennis Polk sold 10,000 shares of the firm’s stock in a transaction that occurred on Thursday, December 1st. The shares were sold at an average price of $122.32, for a total value of $1,223,200.00. Following the completion of the transaction, the director now owns 15,507 shares of the company’s stock, valued at $1,896,816.24. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Insiders own 0.98% of the company’s stock.

Concentrix Company Profile

(Get Rating)

Concentrix Corporation provides technology-infused customer experience (CX) solutions worldwide. The company provides CX process optimization, technology innovation, front- and back-office automation, analytics, and business transformation services. It also offers customer lifecycle management; customer experience/user experience strategy and design; digital transformation; and voice of the customer and analytics solutions.

Read More

Want to see what other hedge funds are holding CNXC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Concentrix Co. (NASDAQ:CNXCGet Rating).

Institutional Ownership by Quarter for Concentrix (NASDAQ:CNXC)

Receive News & Ratings for Concentrix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concentrix and related companies with MarketBeat.com's FREE daily email newsletter.